BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6859379)

  • 1. "Membrane-associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients.
    Taylor DD; Homesley HD; Doellgast GJ
    Am J Reprod Immunol (1980); 1983; 3(1):7-11. PubMed ID: 6859379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of tumor-specific antibodies from effusions of ovarian carcinomas.
    Dorsett BH; Ioachim HL; Stolbach L; Walker J; Barber HR
    Int J Cancer; 1975 Nov; 16(5):779-86. PubMed ID: 1184243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of antigenic components recognized by "membrane-bound" antibodies from ovarian cancer patients.
    Taylor DD; Homesley HD; Doellgast GJ
    Am J Reprod Immunol (1980); 1984 Dec; 6(4):179-84. PubMed ID: 6528883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
    Kutteh WH; Doellgast GJ
    J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of tumour-associated immunoglobulins from ascitic fluid.
    Hill R; Daunter B; Khoo SK; MacKay EV
    Br J Cancer; 1978 Jul; 38(1):154-7. PubMed ID: 687514
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
    Rao GS; Hanjani P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. III. Cytotoxic potential in vitro and characterization of antigen(s).
    Kutteh WH; Baker VV; Doellgast GJ
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1301-6. PubMed ID: 2220942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of immunoglobulins in the effusions of human ovarian epithelial neoplasms.
    Kutteh WH; Gall SA; Doellgast GJ; Allitto BA; Dawson JR
    Am J Obstet Gynecol; 1984 Sep; 150(1):65-9. PubMed ID: 6476028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
    Qian HN; Feng J; Fu TY
    Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of secretory component levels in cyst fluids, ascitic fluids, and sera from ovarian adenocarcinoma patients.
    Klein JL; Gall SA; Dawson JR
    J Natl Cancer Inst; 1978 Jul; 61(1):57-60. PubMed ID: 209204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
    Harlozinska A; Bar JK; Richter R; Cislo M
    Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibility of immunodiagnosis in ovarian cancer.
    Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299
    [No Abstract]   [Full Text] [Related]  

  • 14. Autologous antibodies eluted from membrane fragments isolated from the effusions of human ovarian epithelial neoplasms. I. Quantitation of antibodies.
    Kutteh WH; Welander CE; Homesley HD; Doellgast GJ
    Am J Obstet Gynecol; 1985 Sep; 153(2):124-9. PubMed ID: 4037008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer.
    Silburn PA; Khoo SK; Hill R; Daunter B; Mackay EV
    Diagn Immunol; 1984; 2(1):30-5. PubMed ID: 6209058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies.
    Giancotti FR; Dorsett BH; Qian HN; Cronin WJ; Barber HR; Ioachim HL
    Gynecol Oncol; 1990 Apr; 37(1):24-8. PubMed ID: 2182406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins reactive to carcinoembryonic antigen and their relationship to the antigen in malignant ascitic fluid of ovarian carcinoma.
    Hill R; Khoo SK; Daunter B; Silburn PA; Mackay EV
    Int J Cancer; 1982 Nov; 30(5):587-92. PubMed ID: 7152721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the physicochemical properties of carcinoembryonic antigen in extracts of tumour tissue, ascitic and cyst fluid from ovarian cancer.
    Hill R; Daunter B; Magon H; Khoo SK; Mackay EV
    Aust J Exp Biol Med Sci; 1981 Aug; 59(4):469-76. PubMed ID: 7295221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary.
    Hill R; Daunter B; Khoo SK; Mackay EV
    Mol Immunol; 1981 Jul; 18(7):647-53. PubMed ID: 7300840
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.
    Pattillo RA; Story MT; Ruckert AC
    Cancer Res; 1979 Apr; 39(4):1185-92. PubMed ID: 421202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.